Agenus (AGEN) Capital Expenditures (2010 - 2025)
Agenus (AGEN) posted quarterly Capital Expenditures of $1000.0 for Q2 2025, down 99.78% year-over-year from $461000.0 in Q2 2024, and down 80.0% quarter-over-quarter from $5000.0 in Q1 2025.
Agenus (AGEN) Capital Expenditures (2010 - 2025) Analysis & Trends
Agenus' Capital Expenditures history runs 16 years deep, the most recent figure standing at $1000.0 for Q2 2025.
- In Q2 2025, Capital Expenditures fell 99.78% year-over-year to $1000.0; the TTM figure through Mar 2026 stood at $1000.0 (down 99.82% YoY), while the FY2025 annual figure was $6000.0, down 98.96% from the prior year.
- Capital Expenditures for Q2 2025 stood at $1000.0, down from $5000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $6.0 million in Q2 2022, with the low at -$4.0 million in Q4 2022.
- The 5-year median for Capital Expenditures is $342000.0 (2023), against an average of $1.1 million.
- Peak annual rise in Capital Expenditures reached 2218.37% in 2022, while the deepest fall reached 310.73% in 2022.
- Agenus' Capital Expenditures stood at $1.9 million in 2021, then slumped by 310.73% to -$4.0 million in 2022, then soared by 105.62% to $223000.0 in 2023, then plunged by 67.26% to $73000.0 in 2024, then sank by 98.63% to $1000.0 in 2025.
- Business Quant data shows AGEN's Capital Expenditures at $1000.0 in Q2 2025, $5000.0 in Q1 2025, and $73000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Agenus | 311.95 Mn | 286.43 Mn | 34.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 73,000.00 |
| Dec 31, 2024 | 73,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 461,000.00 |
| Jun 30, 2024 | 461,000.00 |
| Mar 31, 2024 | 35,000.00 |
| Mar 31, 2024 | 35,000.00 |
| Dec 31, 2023 | 223,000.00 |
| Dec 31, 2023 | 223,000.00 |
| Sep 30, 2023 | 3.45 Mn |
| Sep 30, 2023 | 3.45 Mn |
| Jun 30, 2023 | 4.44 Mn |
| Jun 30, 2023 | 4.44 Mn |
| Mar 31, 2023 | 1.84 Mn |
| Mar 31, 2023 | 1.84 Mn |